Stay updated on DTG/3TC in HIV-1 Adolescents Clinical Trial
Sign up to get notified when there's something new on the DTG/3TC in HIV-1 Adolescents Clinical Trial page.

Latest updates to the DTG/3TC in HIV-1 Adolescents Clinical Trial page
- Check4 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.SummaryDifference0.1%
- Check11 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.1%
- Check18 days agoChange DetectedThe web page has been updated to include a new facility name and location, along with relevant publications related to HIV treatment, specifically focusing on the efficacy and safety of Dolutegravir in adolescents. Additionally, the revision number has been updated to reflect the latest version.SummaryDifference2%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.0%
- Check40 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11, indicating a revision in the content.SummaryDifference0.0%
- Check47 days agoChange DetectedThe web page has been updated to version 2.16.10, and the previous service alert regarding planned maintenance has been removed.SummaryDifference0.5%
Stay in the know with updates to DTG/3TC in HIV-1 Adolescents Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DTG/3TC in HIV-1 Adolescents Clinical Trial page.